ENACT
Live / Registered — Registered (as of 08 Dec 2020)
What this means for you
Registered since 08 Dec 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88461015
- Registration number
- 6214070
- Mark type
- Stylized text
- Filed
- 05 Jun 2019
- Published for opposition
- 19 May 2020
- Registered
- 08 Dec 2020
- Attorney of record
- Frances M. Jagla
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of cancer; vaccine preparations for use in connection with cancer and oncology; antibodies sold as an ingredient of pharmaceuticals for the treatment of cancer; antibodies for use in the production of active ingredients of pharmaceuticals and vaccines for use in connection with cancer and oncology; biological preparations for human medical diagnostics and analysis for use in the treatment of cancer; medical diagnostic reagents for use in connection with cancer and oncology; clinical medical reagents for use in connection with cancer and oncology; biological preparations for medical and veterinary purposes in connection with the treatment of cancer
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields in connection with cancer and oncology; research and development of medicines in the fields of cancer and oncology; scientific and technological services and research and design services in the fields of cancer and oncology; biological research, clinical research and medical research in the fields of cancer and oncology; chemical and biochemical analysis services in the fields of cancer and oncology; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology in connection with cancer and oncology; clinical research in the fields of cancer and oncology; providing medical and scientific research information in the field of pharmaceuticals in connection with cancer and oncology; Research and development services in the field of antibodies for use in connection with cancer and oncology
Owner
- INCYTE HOLDINGS CORPORATION, WILMINGTON, DE, US
- MorphoSys AG, Planegg, DE
- MorphoSys AG, Planegg, DE
- MorphoSys AG, Planegg, DE
Prosecution history
- 08 Dec 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Jun 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Jun 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Jun 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 17 Jun 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 01 May 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 24 Apr 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 08 Dec 2020 — REGISTERED-PRINCIPAL REGISTER
- 03 Nov 2020 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 14 Sept 2020 — NOTICE OF ALLOWANCE CANCELLED
- 27 Oct 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Sept 2020 — TEAS DELETE 1(B) BASIS RECEIVED
- 14 Jul 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 May 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED